Archive for May, 2009
12th National Forum on Export Controls
May 19th, 2009
in International Trade & Defense, Regulatory & Compliance |
Get the Latest Insights on:
• What BIS, DDTC and OFAC expect from an effective internal export compliance program
• Preventing liability for foreign third party violations of U.S. export and reexport controls
• Managing an effective restricted parties screening program
• Reducing diversion and trans-shipment risks
• Training U.S. and foreign employees on export controls requirements
• Using the Intra-Company Transfer (ICT) license exception
• Complying with new deminimis requirements
• Integrating AES into your global export data system
• How dual-use items can become ITAR-controlled
• Managing physical and IT access of foreign national employees
• Strengthening your licensing strategy for China exports and reexports
This is the critically acclaimed export controls
event that you cannot afford to miss!
The U.S. continues to step up enforcement in all areas of international trade regulation. Criminal prosecutions, and civil and criminal fines are rising to new, unprecedented levels – with no end on sight! The Departments of State, Commerce, Treasury and Homeland Security are aggressively scrutinizing the export activities of U.S. firms and their foreign trading partners to ensure strict compliance with export controls and economic sanctions laws.
Heightened BIS, DDTC and OFAC compliance expectations, along with recent regulatory changes, have made it even more challenging for U.S. and foreign companies to maintain compliance in a global business environment. As export controls become increasingly confusing and restrictive, how can U.S. exporters implement effective internal export
compliance programs without unduly hampering legitimate trade?
Now in its 12th successful year, American Conference Institute’s National Forum on Export Controls is the event that export professionals rely on for practical guidance toward achieving and maintaining global export compliance. Learn from and network with leading corporate export compliance executives from companies such as General Electric, Northrop Grumman, IBM, Honeywell, Citigroup, Eastman Chemical, Shell, United Technologies and BAE.
Get critical updates and best practices for tackling your most pressing global compliance challenges. Topics will include:
• Screening global transactions: What is necessary for effective risk mitigation
• Minimizing the risk of diversion in export/reexport transactions
• Reducing the risk of liability for foreign third party violations of U.S. export/reexport controls
• Training U.S. and foreign employees to comply with U.S. and local export controls
• Implementing an effective global export controls compliance program
• When and how to use the Intra-Company Transfer (ICT) license exception
• Complying with recent changes to the de minimis rules
• When dual-use items can morph into “ITAR-controlled” items
• Integrating AES into your global export data system: Complying with new Foreign Trade Regulations
• Developing a successful U.S. licensing strategy for China exports and reexports
• Update on EU export controls.
BIG FOUR PHARMACEUTICAL PRICING BOOT CAMP
May 18th, 2009
in Pharmaceuticals / Biotech / Life Sciences, Regulatory & Compliance |
Pricing experts will lay out the fundamentals of “Big Four” pricing and pharmacy benefits
programs in a logical, easy-to-understand format and will provide essential training on how to:
• NAVIGATE the intricacies of the jurisdiction,
functions and operations of the Department
of Veterans Affairs
• NEGOTIATE the FSS contract price
• CALCULATE non-FAMP and FCP
• CORRECT pricing anomalies
• PREPARE for changes to the TRICARE program
• COMPLY with VAOIG and agency regulations
Learn to work effectively and efficiently with one of the largest purchasers of pharmaceutical products
The U.S. government spends billions of dollars per year on the purchase
of drugs making it one of the largest purchasers of pharmaceuticals in
the U.S. Sales to the government typically account for a large portion of a
company’s total revenue, and a company cannot remain competitive in today’s
market without selling to the government. As pharmaceutical manufacturers’
revenue and profits are so closely tied to government contracts and pricing, it
is essential to have a thorough understanding of the Veterans Health Care Act,
Federal Supply Schedule Contracting, Federal Ceiling Price, and pharmacy
benefits programs.
While having the government as a client is lucrative, it can be costly, time
consuming and confusing. Understanding the basics and key terms of “Big
Four” pricing is necessary to ensure that companies do not enter into price
contracts that obligate them to comply with impossible terms. Selling to the VA,
DoD, PHS and Coast Guard also requires constant price calculations and price
reporting. These calculations are often perplexing and result in price anomalies
that can leave even the most seasoned pricing practitioner baffled. On top of
complying with the “Big Four’s” numerous rules and regulations, companies
must also evaluate how their “Big Four” prices affect their overall pricing.
Master the essentials of key “Big Four” pricing concepts and methodologies
ACI’s “Big Four” Pharmaceutical Pricing Boot Camp has been designed to
give novices and experienced practitioners alike a complete understanding of
core pricing competencies. ACI has assembled a faculty of the government
authorities on “Big Four” pricing and pharmacy benefits programs along
with expert pricing practitioners. This distinguished faculty will make sense
of complicated terminology and pricing calculations and teach you how to
navigate the complexities of working with the “Big Four” agencies. Also hear
the latest information on legislative proposals/changes that may impact the
340B program and TRICARE rebates.
